In a bid to help global pharmaceutical company Merck enhance its talent pool, T-Hub is organizing a hackathon, along with Merck, to help it find full-stack ...

(Reuters) - Merck and Co (MRK.N) said on Friday it will buy privately held French company Antelliq Group, which makes digital identification products for ...

Keeping track of pets and farm livestock is a growing multi-billion-pound business (Robert Miller writes). Yesterday Merck, the US healthcare company, ...

Merck (NYSE:MRK) has a strong late stage pharmaceuticals pipeline, and it could be worth as much as $13 billion, or over 6% of its current market value, ...

Merck & Co. boasted some major success in the sales department this year, but the company's commercial organization will still get a makeover for 2019. Adam ...

Merck & Co is set to shake up its executive leadership team after the drugmaker announced its head of global human health, Adam Schechter is to step down ...

Merck & Co. Inc. MRK, -2.52% said Wednesday it is working with Brazilian non-profit Instituto Butantan to develop vaccines to protect against the mosquito-borne ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Adam H. Schechter ...

If you had to make a list of some of the most pressing issues that we're facing as a society, cybersecurity would undoubtedly be right at the top. Cybersecurity is a ...

Despite Sanofi's trouble in the dengue vaccine field, other players aren't deterred. Merck & Co. has struck a deal with Brazil's Butantan Institute to push ahead ...

P&G has completed its acquisition of Merck KGaA's Consumer Health business, in a move it hopes will help boost its flagging sales prospects.

JLL has been appointed to run global office FM operations for science and technology company Merck. The agreement spans 125 locations in 63 countries ...

Germany's Merck KGaA has begun a licensing agreement with Canadian pharma R&D company Cyclica using artificial intelligence (AI) to uncover new drug ...

Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling ...

Roche has partnered with Merck to develop a pan-cancer companion diagnostic to identify solid tumour patients who are eligible for anti-PD-1 therapy.

Roche (OTCQX:RHHBY +0.5%) will collaborate with Merck (MRK +0.4%) to develop a new companion diagnostic test to identify appropriate patients for ...

Pole position: While rivals have hit setbacks, Merck's largely executed on a clinical program for Keytruda that's put the pharma on top in immuno-oncology.

These stocks are seeing increasing bullishness from Wall Street analysts, according to TipRanks.com.

LOWER GWYNEDD ? Gwynedd Mercy University has bought a 154-acre property adjacent to its campus on Sumneytown Pike, nearly doubling the size of the ...

Bayer and Merck & Co have won a breakthrough device designation from the FDA for artificial intelligence software they are jointly developing.

Shortly after the U.S. Supreme Court agreed in June to hear Merck & Co.'s appeal in the years-long Fosamax liability litigation, acting Solicitor General Jefferey ...

Days after Roche's cancer immunotherapy Tecentriq won a long sought-after approval in lung cancer, a Wall Street analyst cut sales forecasts for the drug by ...

Merck's agreement with Cyclica will establish efficiency in its small molecule therapy development with access to Cyclica's AI protein screening platform.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Dec. 10) ...

Palantir Technologies Inc will set up a cancer data analytics joint venture with German lab supplies company Merck KGaA, as the U.S. analytics and security firm ...

Merck and Bayer have been granted FDA Breakthrough Device Designation for the collaborative Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Large-cap pharma stocks have had a decent 2018, with strong earnings momentum primarily responsible for the optimism in the space. Tax cuts enabled ...

Global Financial Private Capital LLC increased its holdings in Merck & Co., Inc. (NYSE:MRK) by 9.7% in the third quarter, according to its most recent 13F filing ...

Dec 11 (Reuters) - Roche Holding AG: * ROCHE TO DEVELOP COMPANION DIAGNOSTIC TEST TO HELP IDENTIFY PATIENTS ELIGIBLE FOR ANTI-PD-1 ...

Merck KGaA and Pfizer's late entrant to the checkpoint inhibitor category has failed a phase III trial in ovarian cancer.

Merck (MRK) closed the most recent trading day at $79.22, moving -0.15% from the previous trading session.

Merck, Darmstadt, Germany has announced that its Embracing Carers? initiative has launched a new campaign to help individuals in the UK reflect and ...

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it practical, we'll show how Merck & Co Inc's ...

Adam Schechter, Merck's president of global human health, will step down from his position Dec. 31. He has been with Merck for 30 years.

It's hard to believe that anyone was taken in this summer when a handful of drug companies announced rollbacks of price increases or price freezes on some of ...

DARMSTADT, Germany, December 6, 2018 /PRNewswire/ -- Not intended for distribution in the U.K. Agreement to screen discovery and early development ...

Merck Animal Health encourages recent doctoral graduates to apply for the 2019 High Quality Pork Ph.D. Award. One graduate will receive the opportunity to ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Robert M. Davis, ...

Merck & Co.'s experimental Ebola vaccine rVSV-ZEBOV has been deployed widely in the Democratic Republic of Congo. But experts are calling on the U.S. ...

In recent trading, shares of Merck & Co Inc (Symbol: MRK) have crossed above the average analyst 12-month target price of $78.39, changing hands.

Ra Pharmaceuticals, Inc. (NASDAQ:RARX) today announced that it has received a development milestone payment under its collaboration agreement with Mer.

Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.

Merck raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling Keytruda cancer treatment.

Irish executive claims German pharma group's actions will damage her reputation.

Stocks - Starbucks, Costco Slump in Premarket; Apple, Merck, Adobe Fall.

Merck's (MRK) two new HIV drugs, Pifeltro and Delstrigo, containing doravirine, get approval in EU.

U.S. stock futures are trading lower this morning as investors prepare for the G-20 meeting between President Trump and Chinese leader Xi Jinping. Over at the ...

DARMSTADT, Germany, December 10, 2018 /PRNewswire/ -- The information contained is not intended for distribution in the UK FDA grants M7824, ...

Merck KGaA of Darmstadt, Germany is poised to expand its R&D facilities in China next year in an effort to support development within the growing market ...

The European Commission approves Merck's (MRK) once-daily combo pill DELSTRIGO (doravirine/lamivudine/tenofovir disoproxil fumarate) and once-daily ...

For a second year, Merck KGaA, Darmstadt, Germany has partnered with TED to explore the art of possibility with visionaries, dreamers, implementers and ...

Merck & Co. raised its U.S. list prices on five drugs in November, including its top-selling cancer immunotherapy, Keytruda, and its top-selling vaccine, Gardasil, ...

Ten years ago this month, Merck Animal Health and the American Association of Equine Practitioners (AAEP) established the Unwanted Horse Veterinary Relief ...

Merck (MRK) closed at $76.34 in the latest trading session, marking a +1.19% move from the prior day.

The shares of Merck & Co., Inc. (NYSE:MRK) went up during the trading session by $1 on Thursday, trading at $79.01. At the moment, the company has a ...

With the acting solicitor general set to participate in oral arguments before the Supreme Court on 7 January, the high court will be deciding a contentious case ...

Keytruda continues to be the biggest growth driver for Merck in 2018. Other oncology assets such as Lynparza and Lenvima have witnessed several positive ...

Pharma companies are industrial partners of Britains first facility dedicated to innovation in vaccines manufacturing.

Merck KGaA, the German pharmaceutical and chemicals company, is teaming up with a London-based startup called V7 to create software that scientists can ...

Let's check in on some recent stock price information on shares of Merck & Co., Inc. (MRK). At the time of writing, shares had most recently hit 76.48. The stock ...

With a focus on the next two years, patent expiration will likely cost MRK in excess of $2B; however, Gardasil and Keytruda sales will help mitigate this. HPV v.

Hipgnosis Songs Fund Limited (HSFL) has acquired the music catalog of US songwriter and producer Jason Boyd, AKA Poo Bear for an undisclosed amount.

Merck KGaA MKKGY, -0.73% and Pfizer Inc. PFE, -1.73% said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a ...

Some 500 women suing Merck & Co over its osteoporosis drug Fosamax have urged the U.S. Supreme Court to uphold a federal appeals court ruling that ...

German life sciences group Merck KGaA (MRK: DE) has successfully completed the sale of its Consumer Health business to Procter & Gamble (NYSE: PG), ...

Merck, Costco, CBS and LVMH are the companies to watch.

Wolfe Research analysts say the market is underestimating the vaccine's potential by more than $2 billion.

Cloud-based platform from Cyclia will be used to put small-molecule therapies to the test.

Merck Sharp and Dohme (MSD) is being advised by ALD Automotive's fleet consultancy team ahead of its planned relocation to London.

GUANGZHOU -- German drugmaker Merck will add and expand research facilities in China and start offering support to pharmaceutical startups there next.

Merck & Co., Inc. (NYSE:MRK) just announced that the European Commission has approved DELSTRIGO and PIFELTRO for the treatment of HIV-1 infection.

Investors need to pay close attention to Merck (MRK) stock based on the movements in the options market lately.

After Ken Frazier's 8 years as CEO, the board recently extended his contract. He heads a storied research company but faces challenges especially on drug ...

Two drug stocks diverged in a yellow wood. And sorry I could not buy both and be one investor, long I stood. My apologies to Robert Frost for butchering his ...

Thank you for being one of our most loyal readers. Please consider supporting community journalism by subscribing. Wendy Winslow, right, and Eric Nguyen, ...

Palantir Technologies, the Silicon Valley data analytics company, and German drug maker Merck KGaA are forming a joint venture to advance cancer research.

A dedication ceremony was held inside the Credit Union's West Point branch in Montgomery County, attended by Merck veterans and employees, as well as ...

CINCINNATI--(BUSINESS WIRE)--Today, the Procter & Gamble Company (NYSE: PG) announced the successful completion of its acquisition of the Consumer ...

Merck KGaA and Palantir Technologies said they will form a joint venture to develop a collaborative technology platform to advance cancer research. The joint ...

The report provides an influential source to evaluate the ?Microbial Cells Analysis Instrument market? and other important details relating to it. The study divulges ...

The share touched its 52-week high Rs 3549 and 52-week low Rs 1041.25 on 03 September, 2018 and 07 December, 2017, respectively.

Roffman Miller Associates Inc increased its stake in Merck & Co Inc New (MRK) by 28.7% based on its latest 2018Q3 regulatory filing with the SEC. Roffman ...

Shell Asset Management Co decreased its stake in Merck & Co Inc (MRK) by 4.03% based on its latest 2018Q3 regulatory filing with the SEC. Shell Asset Gilder ...

Merck KGaA has had a difficult time making headway with their entry into the immune checkpoint space. Recent news in ovarian cancer does not signal new ...

The UK government-led Vaccines Manufacturing Innovation Centre will have pilot and medium-scale capacity and the ability to respond to threats of serious ...

Stanley-Laman Group Ltd decreased its stake in Merck & Co. Inc. (MRK) by 32.99% based on its latest 2018Q3 regulatory filing with the SEC. Stanley-Laman ...

Tealwood Asset Management Inc increased its stake in Merck & Co Inc (MRK) by 8.82% based on its latest 2018Q3 regulatory filing with the SEC. Tealwood ...

P&G (PG) closes the acquisition of Merck KGaA's consumer-health business. This should bolster the company's OTC geographic scale, brand portfolio and ...

The FDA granted Bayer and Merck & Co. a breakthrough device designation for an artificial intelligence-based pattern recognition software used to spot a rare ...

Dublin, Nov. 30, 2018 (GLOBE NEWSWIRE) -- The "Antibiotics: Global Markets to 2023" report has been added to ResearchAndMarkets.com's offering.

Initiation of Phase 1/2 Combination Clinical Trial with Evelo's Monoclonal Microbial, EDP1503, and KEYTRUDA® (pembrolizumab) Across Various Indications ...

Merck's Keytruda finally has some immuno-oncology competition in the previously untreated non-small cell lung cancer market, courtesy of Roche and its freshly ...

Cardinal Capital Management Llc increased its stake in Lakeland Bancorp Inc (LBAI) by 1.05% based on its latest 2018Q3 regulatory filing with the SEC.

Global Microarray Market Report presents an irreplaceable and sheer analysis for Microarray industry. The study report comprises evaluation of numerous ...

FCG Advisors LLC purchased a new position in Merck & Co., Inc. (NYSE:MRK) during the 3rd quarter, according to the company in its most recent filing with the ...

Global Dimethylglycine (DMG) Market Report presents an irreplaceable and sheer analysis for Dimethylglycine (DMG) industry. The study report comprises ...

In the latest trading session, Merck (MRK) closed at $74.79, marking a +0.01% move from the previous day.

Bears reigned on a dull-volume day for Nabors Industries Ltd. (NYSE:NBR) which lost $-0.12 between open and close. The number of shares traders wanted to ...

The Unwanted Horse Veterinary Relief Campaign (UHVRC), which helps protect the health of horses in rescue, celebrates its 10-year anniversary this month.

Global Centrifugal Filters Market has been brewing up and impacting the international economy in terms of growth rate, revenue, sale, market share, and size.